BIOX ApS
CVRCVR number40237216
Company financials
Key figures
Updated 12 Jun 2026
- Return on assets
- 1.9%
- Return on equity
- 1.6%
- Current ratio
- 300.4%
- Equity ratio
- 91%
Profit and loss
| Reporting period | |
|---|---|
Gross profit | 20,636 |
Operating profit | 20,636 |
Finance expenses | 0 |
Tax expense | 4,705 |
Profit/loss for the year | 15,931 |
Balance sheet
| Reporting period | |
|---|---|
Cash and cash equivalents | 53,073 |
Current assets | 135,199 |
Non-current assets | 972,378 |
Total assets | 1,107,577 |
Equity | 1,007,937 |
Liabilities | 99,640 |
Current liabilities | 45,000 |
Working capital
| Reporting period | |
|---|---|
Trade receivables | 0 |
Other current receivables | 4,151 |
Trade payables | 15,000 |
Capital and dividend
| Reporting period | |
|---|---|
Contributed capital | 52,500 |
Retained earnings | 196,982 |
Annual report highlights
Official annual report · 2025
Business and development
Primary activities
Selskabets hovedaktivitet er at designe og udvikle, fremstille, distribuere og handle med produkter, systemer og løsninger inden for industri og sundhed.
Development in activities and financial affairs
Selskabets resultat har svaret til forventningerne.
Risks and material matters
Significant events after the reporting period
Der er efter regnskabsårets afslutning ikke indtruffet begivenheder, som væsentligt vil kunne påvirke selskabets finansielle stilling.
Commitments and security
Contingent liabilities
Ingen.
Create a free account to see up to 9 years of financial history
Create free account